ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Los Angeles, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Los Angeles, CA, USA:

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women with Triple-negative Breast Cancer

(ICI) on on 3-year Event Free Survival (EFS), in women with residual hormone receptor negative, HER2-negative ("triple negative") resectable breast...

Enrolling
Breast Cancer
Procedure: Breast Surgery
Drug: Pembrolizumab

Phase 2

The University of Texas System (UT)
The University of Texas System (UT)

Los Angeles, California, United States and 3 other locations

The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...

Enrolling
Metastatic Breast Cancer
Drug: fulvestrant
Drug: PMD-026

Phase 1, Phase 2

Phoenix Molecular Designs

Los Angeles, California, United States and 4 other locations

to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...

Enrolling
Locally Advanced Breast Cancer
Metastatic Breast Cancer
Drug: U3-1402

Phase 2

SCRI Development Innovations

Duarte, California, United States and 10 other locations

in combination with either of two chemotherapy regimens (weekly paclitaxel or capecitabine) in unresectable/metastatic triple negative breast...

Active, not recruiting
Triple Negative Breast Cancer
Drug: Paclitaxel
Drug: Capecitabine

Phase 1, Phase 2

Providence Health & Services
Providence Health & Services

Los Angeles, California, United States of America and 1 other location

This trial will evaluate the use of immunotherapy and PARP inhibition in a population with incurable advanced breast cancer associa ...

Enrolling
Breast Cancer
Drug: Olaparib
Drug: Pembrolizumab

Phase 2

Yuan Yuan

Los Angeles, California, United States of America

A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...

Active, not recruiting
Breast Cancer
Drug: ARV-471 in combination with Everolimus

Phase 1

Arvinas
Arvinas

Santa Monica, California, United States and 8 other locations

A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, stage II-III, Estrogen Rec ...

Enrolling
Breast Cancer
Drug: Adjuvant Therapy
Drug: Palbociclib

Phase 2

Criterium

Los Angeles, California, United States and 14 other locations

This will be a Phase 2 clinical trial to assess somatostatin receptor (SSTR) expression in Stage IV estrogen receptor positive (ER+) breast ...

Active, not recruiting
Breast Cancer Stage IV
Drug: Copper-64 DOTATATE
Drug: Gallium-68 DOTATATE

Phase 2

Hoag Health Network

Irvine, California, United States

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Enrolling
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

Los Angeles, California, United States and 62 other locations

together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...

Active, not recruiting
HER2 Positive Breast Cancer
Drug: trastuzumab deruxtecan
Drug: tucatinib

Phase 2

Seagen
Seagen

Los Angeles, California, United States and 32 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems